Trade AstraZeneca ^AZN

Verdence Capital Advisors LLC Lowers Position in Astrazeneca Plc $AZN - Daily Political

Is AstraZeneca (LSE:AZN) Still Attractive After Recent Share Price Pullback?

8 Best Stem Cell Therapy Stocks to Buy

Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy

Turtle Creek Wealth Advisors LLC Buys 11,092 Shares of Astrazeneca Plc $AZN - Markets Daily

Rare Disease Clinical Trials Research Report 2026: $21.34 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

5 Best Low Risk High Growth Stocks to Buy Right Now

Caprock Group LLC Has $4.04 Million Holdings in Astrazeneca Plc $AZN

AstraZeneca Trial Wins Add Depth To COPD And Renal Growth Story

EPG Wealth Management LLC Makes New Investment in Astrazeneca Plc $AZN - Markets Daily

TD Waterhouse Canada Inc. Grows Stock Holdings in Astrazeneca Plc $AZN - Markets Daily

Assessing AstraZeneca (LSE:AZN) Valuation As Strong 1‑Year Returns Contrast With Softer Recent Momentum

Astrazeneca (AZN) to Release Quarterly Earnings on Wednesday

Drug Delivery Devices Market Insights, Competitive Landscape, and Forecast Report 2025-2032 - Growing Use of Biologics and Biosimilars, Technological Advancements, and Active Product Developments

Astrazeneca Plc $AZN Shares Acquired by Evergreen Capital Management LLC

Astrazeneca Plc $AZN Shares Bought by Penobscot Investment Management Company Inc. - Stock Observer

IDEAYA And AstraZeneca Collaboration Adds New Dimension To IDE849 And Valuation

AstraZeneca (AZN) Seeks Accelerated Approval for Ultomiris in IgAN Treatment

Germany risks missing out on new drugs, AstraZeneca CEO tells paper

AstraZeneca (AZN) Reports Positive Interim Results from I CAN Tr

AstraZeneca's Ultomiris Achieves Key Milestone in IgA Nephropathy Trial, ETPharma

EGFR Non-Small Cell Lung Cancer Market Report 2026: Revenue to Exceed $10 Billion in 2026, Growing by $730 Million YOY

These are 2 of the hottest FTSE 100 stocks to buy right now, say the experts!

AstraZeneca's Ultomiris hits primary endpoint in rare kidney disease trial - Yahoo News Canada

AstraZeneca's Ultomiris cuts urine protein in late-stage kidney disease trial - AOL

AstraZeneca's Ultomiris cuts urine protein in late-stage kidney disease trial - Yahoo News Canada

I asked ChatGPT for the best FTSE 100 stock for total returns in 2026, and guess what it said…

Family Capital Management Inc. Invests $400,000 in Astrazeneca Plc $AZN - Stock Observer

Hypoxia inducible factor network reflects kidney disease progression in diabetes and sodium-glucose co-transporters inhibition

What to Expect From Amgen's Next Quarterly Earnings Report

AstraZeneca (AZN) Stock: Tozorakimab Achieves Phase III COPD Success in MIRANDA Study

Astrazeneca Plc (NYSE:AZN) Receives Consensus Rating of "Moderate Buy" from Analysts

57% under 'fair value' and 74% forecast earnings growth! 1 FTSE high-tech med stock I just can't pass up

Health: AstraZeneca's tozorakimab delivers sharp reduction in COPD flare‑ups

Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial

Mirae Asset Global Investments Co. Ltd. Acquires 42,665 Shares of Astrazeneca Plc $AZN

GF Fund Management CO. LTD. Has $12.37 Million Stake in Astrazeneca Plc $AZN - Markets Daily

Astrazeneca Plc $AZN Position Raised by Sumitomo Mitsui Trust Group Inc. - Daily Political

Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine

Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026

Innate Pharma présentera des résultats intermédiaires de l'essai de Phase 2 MATISSE évaluant IPH5201 lors d'une session plénière dédiée aux essais cliniques au congrès de l'AACR 2026

Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 115% Five Year Run?

Astrazeneca Plc $AZN Shares Sold by Iams Wealth Management LLC

Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight

Pursuit Wealth Management LLC Takes Position in Astrazeneca Plc $AZN

Assetmark Inc. Buys 25,004 Shares of Astrazeneca Plc $AZN

Role of tumor markers before or during chemotherapy for digestive neuroendocrine carcinomas as an exploratory analysis of JCOG1213

Best Pharmaceutical Stocks To Watch Now - April 15th - Markets Daily

ZWJ Investment Counsel Inc. Lowers Holdings in Astrazeneca Plc $AZN

AZN: Updated Oncology Pipeline Outlook Will Support Multi Year Re Rating

AstraZeneca Readies Saphnelo Launch And Breast Cancer Push As Valuation Question Grows

AstraZeneca's Oncology And Autoimmune Progress Underpins Valuation And Growth Outlook

GSK's share price is under £22, but with a 'fair value' much higher, is it time for me to buy more right now?

Third View Private Wealth LLC Invests $2.95 Million in Astrazeneca Plc $AZN - Daily Political

The versatile interplay between steatotic liver disease and liver cancer

Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial

Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer

Saphnelo® subcutaneous approved in Canada for the treatment of systemic lupus erythematosus

Yousif Capital Management LLC Decreases Stake in Astrazeneca Plc $AZN

GLP-1 Drugs Move Up The Leaderboard As Twin Epidemics Continue To Balloon

ER+/ HER2 - ve Breast Cancer Market Insight, Epidemiology, and Market Forecast Report 2022-2036

Yousif Capital Management LLC Cuts Stake in Astrazeneca Plc $AZN - Daily Political

Rethinking ovarian cancer III: the past decade and future directions

GSK reports promising early results in ovarian and womb cancer drug trial

Cambiar Investors LLC Has $25.39 Million Stock Position in Astrazeneca Plc $AZN - Markets Daily

Astrazeneca Plc $AZN Shares Bought by Apollon Wealth Management LLC

AstraZeneca HPP Trial Data Tests Rare Disease Growth Expectations

Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its 54.8% One-Year Surge?

AstraZeneca India to Sell 64-Acre Bengaluru Manufacturing Site for ₹3,400 Crore as Part of Global Strategy, ETPharma

Feasibility of automated AI-based contouring and stable radiomic feature assessment by HyperSight-CBCT Imaging for adaptive high-precision radiotherapy of prostate cancer

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry

AstraZeneca faces China headwinds and key drug launches as two banks back 20% upside

AstraZeneca's (AZN) "Buy" Rating Reiterated at Jefferies Financial Group

AstraZeneca (LON:AZN) Price Target Raised to £180

Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 55% One-Year Surge?

AstraZeneca India plans to sell 64-acre Bengaluru site for ₹3,400 crore, ETManufacturing

Ailux Appoints Maria Belvisi, Ph.D., as Chief Scientific Officer

AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 crore - The Economic Times

AstraZeneca, Sun Dismiss Patent Suits Over Three Diabetes Drugs

Erste Group Bank Comments on Astrazeneca FY2026 Earnings

Sivik Global Healthcare LLC Makes New Investment in Astrazeneca Plc $AZN

Naviter Wealth LLC Sells 12,014 Shares of Astrazeneca Plc $AZN

£20,000 invested in AstraZeneca shares 5 years ago is now worth…

Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer

Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

Aurobindo Pharma gets USFDA approval for Dapagliflozin & Metformin XR tablets

Biomarker, treatment patterns, and survival differences in metastatic triple-negative breast cancer by race in the United States

AstraZeneca inks MoU with Telangana for AI-enabled lung cancer screening

Alembic gets FDA nod for Dapagliflozin generic, ETPharma

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

TEM stock price analysis: Why Tempus AI Stock Up Today?

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk